El propóleos mitiga el perfil metabólico y lípido-redox inducido por rifampicina/isoniazida en un modelo animal experimental

Autores/as

  • Ahmed Abdulsallam
  • Imad A. Thanoon
  • Rwqaya S. Dawood
  • Abdulrahman I. Abduljabbar

Palabras clave:

isoniazida, rifampicina, propóleo, FBS, TAS, MDA y lípido

Resumen

Las reacciones adversas a medicamentos son la causa más común de abstinencia de medicamentos en entornos de tratamiento crónico. La tuberculosis (TB) se ha considerado una enfermedad recurrente y con recaídas que necesita una terapia a largo plazo. La mayoría de los pacientes sufren los efectos adversos del tratamiento de la TB. Por lo tanto, se utilizaron varios remedios para abordar estos efectos adversos, incluidas las vitaminas antioxidantes, los remedios a base de hierbas y otros. El presente estudio de intervención tiene como objetivo investigar el papel del propóleo en la protección del modelo animal contra el oxidante/antioxidante inducido por la terapia de TB junto con el papel del propóleo en la modulación del perfil metabólico como parte del contexto de la peroxidación lipídica. Para hacerlo, se recolectó suero de ratas expuestas a rifampicina/isoniazida con o sin terapia de propóleos junto con el grupo de control con placebo para comparar. Los resultados han mostrado una reducción significativa (p<0,05) de malondialdehído y una elevación significativa (p<0,05) del estado antioxidante total. Perfil de lípidos mejorado positivamente indicado por colesterol total significativamente reducido, triglicéridos y lipoproteínas de alta densidad elevadas. En conclusión, nuestro estudio confirmó que el propóleos brinda protección contra el trastorno redox y metabólico inducido por los medicamentos de rifampicina/isoniazida que se encuentran en la terapia actual contra la TB; por lo tanto, recomendamos el uso de propóleos como terapia adjunta para los pacientes que toman dichos medicamentos.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Yıldız O, Can Z, Saral Ö, Yuluğ E, Öztürk F, Aliyazıcıoğlu R, Canpolat S, Kolaylı S. Hepatoprotective potential of chestnut bee pollen on carbon tetrachloride-induced hepatic damages in rats. Evidence-based complementary and alternative medicine. 2013;2013. https://doi.org/10.1155/2013/461478

Denisow B, Denisow‐Pietrzyk M. Biological and therapeutic properties of bee pollen: a review. Journal of the Science of Food and Agriculture. 2016 Oct;96(13):4303-9. https://doi.org/10.1002/jsfa.7729

Sun C, Wu Z, Wang Z, Zhang H. Effect of ethanol/water solvents on phenolic profiles and antioxidant properties of Beijing propolis extracts. Evidence-Based Complementary and Alternative Medicine. 2015 Jul;2015. https://doi.org/10.1155/2015/595393

Kumari S, Naik P, Vishma BL, Salian SR, Devkar RA, Khan S, Mutalik S, Kalthur G, Adiga SK. Mitigating effect of Indian propolis against mitomycin C induced bone marrow toxicity. Cytotechnology. 2016 Oct;68(5):1789-800. https://doi.org/10.1007/s10616-015-9931-4

Alyane M, Kebsa LB, Boussenane HN, Rouibah H, Lahouel M. Cardioprotective effects and mechanism of action of polyphenols extracted from propolis against doxorubicin toxicity. Pakistan Journal of Pharmaceutical Sciences. 2008 Jul 1;21(3).

Jin X, Liu Q, Jia L, Li M, Wang X. Pinocembrin attenuates 6-OHDA-induced neuronal cell death through Nrf2/ARE pathway in SH-SY5Y cells. Cellular and molecular neurobiology. 2015 Apr;35(3):323-33. https://doi.org/10.1007/s10571-014-0128-8

Silva RB, Santos NA, Martins NM, Ferreira DA, Barbosa Jr F, Souza VO, Kinoshita A, Baffa O, Del-Bel E, Santos AC. Caffeic acid phenethyl ester protects against the dopaminergic neuronal loss induced by 6-hydroxydopamine in rats. Neuroscience. 2013 Mar 13;233:86-94. https://doi.org/10.1016/j.neuroscience.2012.12.041

Izuta H, Shimazawa M, Tsuruma K, Araki Y, Mishima S, Hara H. Bee products prevent VEGF-induced angiogenesis in human umbilical vein endothelial cells. BMC complementary and alternative medicine. 2009 Dec;9(1):1-0. https://doi.org/10.1186/1472-6882-9-45

Bazmandegan G, Boroushaki MT, Shamsizadeh A, Ayoobi F, Hakimizadeh E, Allahtavakoli M. Brown propolis attenuates cerebral ischemia-induced oxidative damage via affecting antioxidant enzyme system in mice. Biomedicine & Pharmacotherapy. 2017 Jan 1;85:503-10. https://doi.org/10.1016/j.biopha.2016.11.057

Baltas N, Karaoglu SA, Tarakci C, Kolayli S. Effect of propolis in gastric disorders: inhibition studies on the growth of Helicobacter pylori and production of its urease. Journal of enzyme inhibition and medicinal chemistry. 2016 Nov 2;31(sup2):46-50.https://doi.org/10.1080/14756366.2016.1186023.

LeBlanc BW, Davis OK, Boue S, DeLucca A, Deeby T. Antioxidant activity of Sonoran Desert bee pollen. Food chemistry. 2009 Aug 15; 115(4):1299-305. https://doi.org/10.1016/j.foodchem.2009.01.055

Ferreira D, Rocha HC, Kreutz LC, Loro VL, Marqueze A, Koakoski G, Santos da Rosa JG, Gusso D, Oliveira TA, de Abreu MS, Barcellos LJ. Bee products prevent agrichemical-induced oxidative damage in fish. PloS one. 2013 Oct 3;8(10):e74499. https://doi.org/10.1371/journal.pone.0074499

Kim SB, Jo YH, Liu Q, Ahn JH, Hong IP, Han SM, Hwang BY, Lee MK. Optimization of extraction condition of bee pollen using response surface methodology: correlation between anti-melanogenesis, antioxidant activity, and phenolic content. Molecules. 2015 Nov;20(11):19764-74. https://doi.org/10.3390/molecules201119656

de Florio Almeida J, dos Reis AS, Heldt LF, Pereira D, Bianchin M, de Moura C, Plata-Oviedo MV, Haminiuk CW, Ribeiro IS, da Luz CF, Carpes ST. Lyophilized bee pollen extract: A natural antioxidant source to prevent lipid oxidation in refrigerated sausages. LWT-Food Science and Technology. 2017 Mar 1; 76:299-305. https://doi.org/10.1016/j.lwt.2016.06.017

Rzepecka-Stojko A, Stojko J, Kurek-Górecka A, Górecki M, Kabała-Dzik A, Kubina R, Moździerz A, Buszman E. Polyphenols from bee pollen: structure, absorption, metabolism and biological activity. Molecules. 2015 Dec; 20(12):21732-49. https://doi.org/10.3390/molecules201219800

Arct J, Pytkowska K. Flavonoids as components of biologically active cosmeceuticals. Clinics in dermatology. 2008 Jul 1; 26(4):347-57. https://doi.org/10.1016/j.clindermatol.2008.01.004

Panche AN, Diwan AD, Chandra SR. Flavonoids: an overview. Journal of nutritional science. 2016;5. https://doi.org/10.1017/jns.2016.41

Bonamigo T, Campos JF, Oliveira AS, Torquato HF, Balestieri JB, Cardoso CA, Paredes-Gamero EJ, de Picoli Souza K, Dos Santos EL. Antioxidant and cytotoxic activity of propolis of Plebeia droryana and Apis mellifera (Hymenoptera, Apidae) from the Brazilian Cerrado biome. PLoS One. 2017 Sep 12;12(9):e0183983. https://doi.org/10.1371/journal.pone.0183983

Bonamigo T, Campos JF, Alfredo TM, Balestieri JB, Cardoso CA, Paredes-Gamero EJ, de Picoli Souza K, Dos Santos EL. Antioxidant, cytotoxic, and toxic activities of propolis from two native bees in Brazil: Scaptotrigona depilis and Melipona quadrifasciata anthidioides. Oxidative medicine and cellular longevity. 2017 Mar 9;2017. https://doi.org/10.1155/2017/1038153

Bankova V. Chemical diversity of propolis and the problem of standardization. Journal of ethnopharmacology. 2005 Aug 22; 100(1-2):114-7. https://doi.org/10.1016/j.jep.2005.05.004

Bittencourt ML, Ribeiro PR, Franco RL, Hilhorst HW, de Castro RD, Fernandez LG. Metabolite profiling, antioxidant and antibacterial activities of Brazilian propolis: Use of correlation and multivariate analyses to identify potential bioactive compounds. Food Research International. 2015 Oct 1;76:449-57. https://doi.org/10.1016/j.foodres.2015.07.008

Narimane S, Demircan E, Salah A, Salah R. Correlation between antioxidant activity and phenolic acids profile and content of Algerian propolis: Influence of solvent. Pakistan journal of pharmaceutical sciences. 2017 Jul 2;30.

Andrade JK, Denadai M, de Oliveira CS, Nunes ML, Narain N. Evaluation of bioactive compounds potential and antioxidant activity of brown, green and red propolis from Brazilian northeast region. Food Research International. 2017 Nov 1; 101:129-38. https://doi.org/10.1016/j.foodres.2017.08.066

Zhang C, Shen X, Chen J, Jiang X, Hu F. Identification of free radical scavengers from Brazilian green propolis using off‐line HPLC‐DPPH assay and LC‐MS. Journal of food science. 2017 Jul;82(7):1602-7. https://doi.org/10.1111/1750-3841.13730

Socha R, Gałkowska D, Bugaj M, Juszczak L. Phenolic composition and antioxidant activity of propolis from various regions of Poland. Natural Product Research. 2015 Mar 4;29(5):416-22. https://doi.org/10.1080/14786419.2014.949705

Mujica V, Orrego R, Pérez J, Romero P, Ovalle P, Zúñiga-Hernández J, Arredondo M, Leiva E. The role of propolis in oxidative stress and lipid metabolism: a randomized controlled trial. Evidence-Based Complementary and Alternative Medicine. 2017 Apr 30;2017. https://doi.org/10.1155/2017/4272940

Jasprica I, Mornar A, Debeljak Ž, Smolčić-Bubalo A, Medić-Šarić M, Mayer L, Romić Ž, Bućan K, Balog T, Sobočanec S, Šverko V. In vivo study of propolis supplementation effects on antioxidative status and red blood cells. Journal of Ethnopharmacology. 2007 Apr 4;110(3):548-54. https://doi.org/10.1016/j.jep.2006.10.023

Fang Y, Li J, Ding M, Xu X, Zhang J, Jiao P, Han P, Wang J, Yao S. Ethanol extract of propolis protects endothelial cells from oxidized low-density lipoprotein-induced injury by inhibiting lectin-like oxidized low density lipoprotein receptor-1-mediated oxidative stress. Experimental Biology and Medicine. 2014 Dec; 239(12):1678-87. https://doi.org/10.1177/1535370214541911

Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T. An endothelial receptor for oxidized low-density lipoprotein. Nature. 1997 Mar;386(6620):73-7. https://doi.org/10.1038/386073a0

Tian H, Sun HW, Zhang JJ, Zhang XW, Zhao L, Guo SD, Li YY, Jiao P, Wang H, Qin SC, Yao ST. Ethanol extract of propolis protects macrophages from oxidized low density lipoprotein-induced apoptosis by inhibiting CD36 expression and endoplasmic reticulum stress-C/EBP homologous protein pathway. BMC Complementary and Alternative Medicine. 2015 Dec;15(1):1-2. https://doi.org/10.1186/s12906-015-0759-4.

Althanoon Z, Faisal IM, Ahmad AA, Merkhan MM, Merkhan MM. Pharmacological aspects of statins are relevant to their structural and physicochemical properties. Systematic Reviews in Pharmacy. 2020;11(7):167-71. ps://doi.org/10.31838/srp.2020.7.27

Almukhtar HM, Faisal IM, Merkhan MM. Effects of statins on platelet count in hyperlipidemic patients. International Journal of Pharmaceutical Research. 2020 Apr;12(2):2640-4. https://doi.org/10.31838/ijpr/2020.12.02.357

Almukhtar HM, Faisal IM, Merkhan MM. Acute effect of atorvastatin in comparison with rosuvastatin on glucose homeostasis in hypercholesteremic patients. Pharmacology. 2021;25:25-34.

Younis HY, Imad A. Effect of zinc as an add on to metformin therapy on serum lipid profile and uric acid in type 2 diabetes mellitus patients. Curr topics in Pharmacology. 2021;25.

Almukhtar HM, Faisal IM, Merkhan MM. Short-term treatment with Atorvastatin selectively decreases Lymphocyte count. Research Journal of Pharmacy and Technology. 2022 Feb 26;15(2):689-94. https://doi.org/10.52711/0974-360X.2022.00114

Althanoon ZA, Merkhan MM. EFFECTS OF ZINC SUPPLEMENTATION ON METABOLIC STATUS IN PATIENTS WITH METABOLIC SYNDROME. Acta Poloniae Pharmaceutica. 2021:78(4) pp.521-6. https://doi.org/ 10.32383/appdr/141348

Zhao L, Pu L, Wei J, Li J, Wu J, Xin Z, Gao W, Guo C. Brazilian green propolis improves antioxidant function in patients with type 2 diabetes mellitus. International journal of environmental research and public health. 2016 May;13(5):498.https://doi.org/10.3390/ijerph13050498

Zambrano AM, Díaz CE, Zamora EE, Laverde AJ, Adame FT, Ronda JR, Quintanilla SB, Uvidia VC. Salud mental de los pacientes con enfermedades crónicas durante la pandemia por COVID-19. Sindrome Cardiometabólico. 2020;10(1):20-4.

Andrade AV, Cruz JG, Jiménez SI, Demera JA, Ronda JR, Uzhca BS, Tinoco YJ, Lara JC. Promoción de la actividad física en los pacientes con enfermedad cardiovascular durante el confinamiento por covid-19. Sindrome Cardiometabólico. 2020;10(1):16-9.

Descargas

Publicado

2023-04-05

Cómo citar

Abdulsallam, A. ., Thanoon, I. A. ., Dawood, R. S. ., & Abduljabbar, A. I. . (2023). El propóleos mitiga el perfil metabólico y lípido-redox inducido por rifampicina/isoniazida en un modelo animal experimental. AVFT – Archivos Venezolanos De Farmacología Y Terapéutica, 41(7). Recuperado a partir de http://saber.ucv.ve/ojs/index.php/rev_aavft/article/view/25952